Focus on Lipids Care

Back to articles

Alternatives for patients with muscle-related statin intolerance


Use of evolocumab (Repatha—Amgen) resulted in greater reductions in LDL levels compared with ezetimibe (Zetia—Merck) and was well tolerated in patients with elevated LDL levels and a history of muscle-related statin intolerance, according to results of the GAUSS-3 trial published in JAMA.